GUIDed Growth of the Proximal Femur to Prevent Further Hip MigrAtion in CErebral Palsy Patients

NCT ID: NCT06118736

Last Updated: 2024-10-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

84 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-03-06

Study Completion Date

2030-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In recent literature, the potential of guided growth of the proximal femur to modify hip growth in patients with cerebral palsy has been shown. Using medial hemi-epiphysiodesis of the proximal femur (TMH-PF) morphology of hips at risk of symptomatic (sub)luxation in cerebral palsy (CP) can be changed, aiming to reduce further hip migration and the need for more invasive surgical treatment modalities. Further research is necessary to assess if the results of TMH-PF in combination with adductor tenotomies are significantly better than the results of the current standard of care; adductor tenotomies alone.

The investigators objective is to determine whether guided growth of the proximal femur decreases the risk of further hip migration and need for further surgery in cerebral palsy patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cerebral Palsy Hip Dislocation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adductor tenotomy + Temporary Medial Hemi-epiphysiodesis of the proximal femur

Standard care + intervention

Group Type EXPERIMENTAL

Temporary Medial Hemi-epiphysiodesis of the proximal femur

Intervention Type PROCEDURE

Temporary Medial Hemi-epiphysiodesis of the proximal femur

Adductor tenotomy

Standard care

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Temporary Medial Hemi-epiphysiodesis of the proximal femur

Temporary Medial Hemi-epiphysiodesis of the proximal femur

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Spastic CP
* GMFCS level IV-V
* Aged 2-8 years
* At least one hip with an abduction in flexion ≤ 40 degrees
* Migration percentage of 30-50%
* Head shaft angle \> 145

Exclusion Criteria

* Not fit for surgery
* History of bony hip surgery to the affected hip
* Severe acetabular dysplasia defined as a gothic arch, an incongruent joint or an acetabular index \> 30 degrees, consistent with A2 and A3 acetabular deformity according to Robin and Graham in an adequately performed radiographs
Minimum Eligible Age

2 Years

Maximum Eligible Age

8 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Erasmus Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Merel Roelen

MD, PhD candidate

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jaap Tolk, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Erasmus Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Amsterdam UMC

Amsterdam, , Netherlands

Site Status NOT_YET_RECRUITING

UMC Groningen

Groningen, , Netherlands

Site Status RECRUITING

Maastricht UMC

Maastricht, , Netherlands

Site Status RECRUITING

Sint Maartenskliniek

Nijmegen, , Netherlands

Site Status NOT_YET_RECRUITING

Erasmus MC

Rotterdam, , Netherlands

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Merel Roelen, MD

Role: CONTACT

+31639173455

Jaap Tolk, MD PhD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Melinda Witbreuk, MD PhD

Role: primary

Sophie Moerman, MD PhD

Role: primary

Adhiambo Witlox, MD PhD

Role: primary

Arno ten Ham, MD

Role: primary

Merel Roelen, MD

Role: primary

Jaap Tolk, MD PhD

Role: backup

Renee van Stralen, MD

Role: backup

References

Explore related publications, articles, or registry entries linked to this study.

van Stralen RA, Roelen MCR, Moerman S, Witbreuk MMEH, Witlox MA, Ten Ham A, Eygendaal D, Reijman M, Tolk JJ. GUIDANCE study: guided growth of the proximal femur to prevent further hip migration in patients with cerebral palsy-study protocol for a multicentre randomised controlled trial. BMJ Open. 2024 Dec 11;14(12):e091073. doi: 10.1136/bmjopen-2024-091073.

Reference Type DERIVED
PMID: 39663160 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PanamaID 10082

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Mild Hip Dysplasia
NCT03530878 WITHDRAWN NA
PMCF 8 Year Results TRJ®
NCT04542174 COMPLETED
Cephalic Femoral Heads Follow Up
NCT06873568 NOT_YET_RECRUITING